BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31217420)

  • 21. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.
    Drapeau N; Lizotte F; Denhez B; Guay A; Kennedy CR; Geraldes P
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1188-98. PubMed ID: 23531619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease.
    Nicholson RJ; Pezzolesi MG; Summers SA
    Front Endocrinol (Lausanne); 2020; 11():622692. PubMed ID: 33584550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway.
    Tao M; Zheng D; Liang X; Wu D; Hu K; Jin J; He Q
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
    Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
    Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal Structure of the Acid Sphingomyelinase-like Phosphodiesterase SMPDL3B Provides Insights into Determinants of Substrate Specificity.
    Gorelik A; Heinz LX; Illes K; Superti-Furga G; Nagar B
    J Biol Chem; 2016 Nov; 291(46):24054-24064. PubMed ID: 27687724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor.
    Lay AC; Hurcombe JA; Betin VMS; Barrington F; Rollason R; Ni L; Gillam L; Pearson GME; Østergaard MV; Hamidi H; Lennon R; Welsh GI; Coward RJM
    Diabetologia; 2017 Nov; 60(11):2299-2311. PubMed ID: 28852804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease.
    Majumder S; Hadden MJ; Thieme K; Batchu SN; Niveditha D; Chowdhury S; Yerra VG; Advani SL; Bowskill BB; Liu Y; Vakili H; Alghamdi TA; White KE; Geldenhuys L; Siddiqi FS; Advani A
    Diabetologia; 2019 Nov; 62(11):2129-2142. PubMed ID: 31399844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
    Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
    Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
    Jin J; Ye M; Hu K; Gong J; He Q
    Histol Histopathol; 2019 Jun; 34(6):671-682. PubMed ID: 30475382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Krüppel‑like factor 4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway.
    Gong J; Zhan H; Li Y; Zhang W; Jin J; He Q
    Mol Med Rep; 2019 Oct; 20(4):3240-3248. PubMed ID: 31432191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTPN14 deficiency alleviates podocyte injury through suppressing inflammation and fibrosis by targeting TRIP6 in diabetic nephropathy.
    Lin Y; Shao Z; Zhao M; Li J; Xu X
    Biochem Biophys Res Commun; 2021 Apr; 550():62-69. PubMed ID: 33684622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects and mechanisms of total flavones of Abelmoschus manihot in improving insulin resistance and podocyte epithelial-mesenchymal transition in diabetic kidney disease based on IRS1/PI3K/Akt pathway].
    Wang Y; Cao DW; Wan YG; Mu GL; Wu W; Fang QJ; Li YJ; Cha SY; Tu Y; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2646-2656. PubMed ID: 37282926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crosstalk Between SMPDL3b and NADPH Oxidases Mediates Radiation-Induced Damage of Renal Podocytes.
    Azzam P; Francis M; Youssef T; Mroueh M; Daher AA; Eid AA; Fornoni A; Marples B; Zeidan YH
    Front Med (Lausanne); 2021; 8():732528. PubMed ID: 34660640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease.
    Chang TT; Li SY; Lin LY; Chen C; Chen JW
    Biomed Pharmacother; 2023 May; 161():114450. PubMed ID: 36863097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PGC-1α ameliorates kidney fibrosis in mice with diabetic kidney disease through an antioxidative mechanism.
    Zhang L; Liu J; Zhou F; Wang W; Chen N
    Mol Med Rep; 2018 Mar; 17(3):4490-4498. PubMed ID: 29344670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin signaling: implications for podocyte biology in diabetic kidney disease.
    Coward R; Fornoni A
    Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):104-10. PubMed ID: 25415617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Podocytes, signaling pathways, and vascular factors in diabetic kidney disease.
    Brosius FC; Coward RJ
    Adv Chronic Kidney Dis; 2014 May; 21(3):304-10. PubMed ID: 24780459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saturated fatty acids induce insulin resistance in podocytes through inhibition of IRS1 via activation of both IKKβ and mTORC1.
    Denhez B; Rousseau M; Spino C; Dancosst DA; Dumas MÈ; Guay A; Lizotte F; Geraldes P
    Sci Rep; 2020 Dec; 10(1):21628. PubMed ID: 33303821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin signaling to the glomerular podocyte is critical for normal kidney function.
    Welsh GI; Hale LJ; Eremina V; Jeansson M; Maezawa Y; Lennon R; Pons DA; Owen RJ; Satchell SC; Miles MJ; Caunt CJ; McArdle CA; Pavenstädt H; Tavaré JM; Herzenberg AM; Kahn CR; Mathieson PW; Quaggin SE; Saleem MA; Coward RJM
    Cell Metab; 2010 Oct; 12(4):329-340. PubMed ID: 20889126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Berberine protects against diabetic kidney disease via promoting PGC-1α-regulated mitochondrial energy homeostasis.
    Qin X; Jiang M; Zhao Y; Gong J; Su H; Yuan F; Fang K; Yuan X; Yu X; Dong H; Lu F
    Br J Pharmacol; 2020 Aug; 177(16):3646-3661. PubMed ID: 31734944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.